|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and other amortization | |||||
| Net foreign currency gain on financing activities | |||||
| Amortization of acquisition-related intangible assets | |||||
| Amortization of financing costs and debt discounts | |||||
| Share-based compensation | |||||
| Deferred income taxes | |||||
| Net gain on sale of business and distribution of other assets | |||||
| Gain on sale of investments | |||||
| (Income) loss from investments in unconsolidated affiliates | |||||
| Distributions from unconsolidated affiliates | |||||
| Non-cash impairment charges | |||||
| Non-cash settlement charge for terminated pension plans | |||||
| Non-cash foreign currency exchange losses | |||||
| Other operating activities | |||||
| Changes in assets and liabilities, net of effects from acquisitions and dispositions: | |||||
| Trade accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Contract costs | |||||
| Accounts payable and other liabilities | |||||
| Contract liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures, including capitalized software and other intangibles | |||||
| Net proceeds from sale of business and other assets | |||||
| Merchant cash advances, including Clover Capital program | |||||
| Repayment of merchant cash advances, including Clover Capital program | |||||
| Settlement anticipation cash advances, net | |||||
| Payments for acquisition of businesses, net of cash acquired | |||||
| Distributions from unconsolidated affiliates | |||||
| Purchases of investments | |||||
| Proceeds from sale of investments | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Debt proceeds | |||||
| Debt repayments | |||||
| Net (repayments of) borrowings from commercial paper and short-term borrowings | |||||
| Payments of debt financing costs | |||||
| Proceeds from issuance of treasury stock | |||||
| Purchases of treasury stock, including employee shares withheld for tax obligations | |||||
| Settlement activity, net | |||||
| Distributions paid to noncontrolling interests and redeemable noncontrolling interest | |||||
| Payments to acquire noncontrolling interests of consolidated subsidiaries | |||||
| Payments of acquisition-related contingent consideration | |||||
| Settlement of derivative contracts | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning balance | |||||
| Cash and cash equivalents, ending balance | |||||
Loading...